Abstract: Disclosed herein are novel methods and compositions for targeting drug delivery systems to specific cells. One aspect relates to a drug delivery system comprising an elastin-like peptide (ELP) component and a ligand selected from the group consisting of an polymeric immunoglobulin receptor binding site in the C?3 domain of dimeric human IgA (mIgA) and knob capable of either drug encapsulation or drug attachment. Further aspects relate to drug delivery systems comprising an elastin-like peptide (ELP) component and a ligand; wherein the ligand specifically binds to a receptor selected from the group consisting of coxsackievirus and adenovirus receptor (CAR) and polymeric immunoglobulin receptor (pIgR). Further aspects include the novel transcytosing properties of the elastin-like peptide and the ligand, knob. Also provided are methods and pharmaceutical compositions comprising the disclosed therapeutics.

Abstract: Disclosed herein are novel methods and compositions for targeting drug delivery systems to specific cells. One aspect relates to a drug delivery system comprising an elastin-like peptide (ELP) component and a ligand selected from the group consisting of mIgA and knob capable of either drug encapsulation or drug attachment. Further aspects relate to drug delivery systems comprising an elastin-like peptide (ELP) component and a ligand; wherein the ligand specifically binds to a receptor selected from the group consisting of CAR and pIgR. Further aspects include the novel transcytosing properties of the elastin-like peptide and the ligand, knob. Also provided are methods and pharmaceutical compositions comprising the disclosed therapeutics.

Abstract: The disclosure provides an information processing method, an electronic device and a wearable electronic device. The information processing method comprises: obtaining a first physiological parameter at a user's first part by using a first wearable electronic device; generating a first identification code corresponding to the first physiological parameter; acquiring a second identification code transmitted from a second wearable electronic device which communicates with the first wearable electronic device; judging whether the first identification code matches the second identification code, to obtain a judgment result; and establishing a connection between the first wearable electronic device and the second wearable electronic device, if the judgment result indicates that the first identification code matches the second identification code.

Abstract: The disclosure provides an information processing method, an electronic device and a wearable electronic device. The information processing method comprises: obtaining a first physiological parameter at a user's first part by using a first wearable electronic device; generating a first identification code corresponding to the first physiological parameter; acquiring a second identification code transmitted from a second wearable electronic device which communicates with the first wearable electronic device; judging whether the first identification code matches the second identification code, to obtain a judgment result; and establishing a connection between the first wearable electronic device and the second wearable electronic device, if the judgment result indicates that the first identification code matches the second identification code.

Abstract: Disclosed herein are novel methods and compositions for targeting drug delivery systems to specific cells. One aspect relates to a drug delivery system comprising an elastin-like peptide (ELP) component and a ligand selected from the group consisting of mIgA and knob capable of either drug encapsulation or drug attachment. Further aspects relate to drug delivery systems comprising an elastin-like peptide (ELP) component and a ligand; wherein the ligand specifically binds to a receptor selected from the group consisting of CAR and pIgR. Further aspects include the novel transcytosing properties of the elastin-like peptide and the ligand, knob. Also provided are methods and pharmaceutical compositions comprising the disclosed therapeutics.